Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

How a holistic approach to horseshoe crab sustainability will allow the industry to maintain stocks while protecting patients.

Clinical supply chains are inherently dynamic and ambiguous, contributing to a high degree of uncertainty.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

We interview Mary Lavin, President of Sartorius North America, about her career.

Lonza and Cytena combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of Pichia pastoris as an expression system.

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.